Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 08 February 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Liver transplantation influences fatigue in patients with primary biliary cirrhosis

A study in the latest issue of the Journal of Hepatology investigates the effect of liver transplantation on fatigue in patients with primary biliary cirrhosis.

News image

The role of liver transplantation for the relief of fatigue in patients with primary primary biliary cirrhosis is unclear.

While many centers exclude fatigue as an indication for transplantation, there have been no studies to prospectively evaluate the impact of liver transplantation on fatigue.

Dr Marco Carbone and colleagues assessed the severity of fatigue in liver transplantation candidates with primary biliary cirrhosis and the impact of liver transplantation on fatigue.

In a prospective, longitudinal study, the team used the primary biliary cirrhosis-40 questionnaire in 49 adult patients with primary biliary cirrhosis at listing and at 6, 12, and 24 months after liver transplantation.

The team also assessed 2 sex- and age-matched cohorts of community controls, and non-transplanted primary biliary cirrhosis patients.

The calculated pooled gastric cancer incidence-rate was about 0.3% per person-years
Journal of Hepatology

Correlation analysis was used to assess the relationship between liver function and fatigue.

ANOVA was used to compare the variation of fatigue score before and after liver transplantation.

There was no correlation between MELD and fatigue before liver transplantation.

The doctors found that overall, the fatigue score after liver transplantation was substantially lower than before liver transplantation, falling from 41 pre-transplant to 28, 29, 26 at 6, 12, and 24 months after liver transplantation, respectively.

The same improvement of fatigue was observed in both low-MELD and high-MELD patients.

The team noted that improvement in fatigue was also evident in the comparison with a “non-transplant primary biliary cirrhosis” control group.

However, 44% of the total cohort, and 47% of those with low-MELD, for whom the probability of dying of liver transplantation may be higher than that of dying without liver transplantation, had moderate to severe fatigue at 2 years after liver transplantation.

Moreover, fatigue scores at 2 years were higher in the transplant primary biliary cirrhosis cohort compared to a cohort of community controls.

Dr Carbone's team concludes, "Liver transplantation is associated with improvement in fatigue in patients with primary biliary cirrhosis."

"However, a substantial proportion of patients continue to suffer from significant fatigue after two years."

"Whether the improvement is enough to justify organ allocation in patients with fatigue alone, without liver failure, is still an open issue."

"Certainly, in the era of organ shortage, with many patients dying waiting for a graft, this may not represent the optimal use of donated deceased organs."

J of Hepatol 2013: 59(3): 490-494
23 September 2013

Go to top of page Email this page Email this page to a colleague

 08 February 2016 
Cognitive function in Crohn's disease
 08 February 2016 
Cancelled colonoscopy appointments
 08 February 2016 
Immunity in the human gut
 05 February 2016 
Treatment for ileal pouch-anal anastomosis for Crohn’s colitis
 05 February 2016 
Helicobacter cinaedi bacteremia
 05 February 2016 
Methotrexate and remission in ulcerative colitis
 04 February 2016 
Diabetes and liver cancer
 04 February 2016 
Colorectal cancer screening
 04 February 2016 
H. pylori and coronary heart disease 
 03 February 2016 
Acute diverticulitis and IBS 
 03 February 2016 
Microbiota of the colonic mucosa and chronic constipation
 03 February 2016 
Guidelines for chronic pancreatitis
 02 February 2016 
Ramosetron and IBS-diarrhea
 02 February 2016 
IBD emergency department visits
 02 February 2016 
Probiotics for H. pylori management
 01 February 2016 
Managing HBV in pregnancy
 01 February 2016 
Depressive symptoms in IBD 
 01 February 2016 
Obesity and hepatocellular carcinoma risk
 29 January 2016 
Colorectal cancer after colonoscopy
 29 January 2016 
Acute diverticulitis in immunosuppressed patients
 29 January 2016 
Vitamin D and colorectal cancer risk
 28 January 2016 
Tissue anti-TNF drug levels and IBD
 28 January 2016 
First line treatment of H. pylori infection
 28 January 2016 
Tetracycline for rosacea increases the risk of IBD
 27 January 2016 
Steroids in children with Crohn's
 27 January 2016 
Self-management IBS program 
 27 January 2016 
Human gut microbiome in IBD 
 26 January 2016 
Smoking and symptomatic diverticular disease
 26 January 2016 
Step-down therapy in PPI-responsive esophageal eosinophilia 
 26 January 2016 
Diet and IBD risk
 25 January 2016 
IBD monitoring using smartphones
 25 January 2016 
Self-management IBS program
 25 January 2016 
Colorectal cancer after a negative screening sigmoidoscopy
 22 January 2016 
Length of Barrett's and cancer
 22 January 2016 
Psychosocial interventions and alcohol abstinence in chronic liver disease
 22 January 2016 
Helicobacter pylori antibiotic resistance
 21 January 2016 
Increasing adenoma detection rate during colonoscope withdrawal
 21 January 2016 
Microscopic colitis current concepts
 21 January 2016 
Statins as a management strategy for constipation 
 20 January 2016 
Health status after bariatric surgery
 20 January 2016 
Hep E infection in West Africa
 20 January 2016 
Preventing endoscopic bacterial transmission
 19 January 2016 
PPIs and phlebotomy in hereditary hemochromatosis
 19 January 2016 
Predicting liver cirrhosis in Hep C
 19 January 2016 
Frozen vs fresh fecal microbiota transplantation
 18 January 2016 
Hospitalization for diverticulitis in the USA
 18 January 2016 
H. pylori and gastric cancer across Europe
 18 January 2016 
Enteral nutrition in children with Crohn's
 15 January 2016 
Alcohol- and HCV-related hepatocellular carcinoma
 15 January 2016 
Recurrent colonic diverticulitis
 15 January 2016 
Colonic diverticula and colorectal cancer risk
 14 January 2016 
Risk stratification of incidentally discovered gallstones
 14 January 2016 
Treatment of refractory cholestatic pruritus
 14 January 2016 
Colonic diverticula and colorectal cancer risk 
 13 January 2016 
C-section delivery and IBD risk
 13 January 2016 
Primary biliary cholangitis treatment with incomplete UDCA response
 13 January 2016 
Colon cancer screening rates 
 12 January 2016 
Eosinophilic esophagitis endoscopic reference score
 12 January 2016 
Web-based tool for Crohn's disease
 12 January 2016 
IBD patients willingnes to accept medication risk

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us